| Title | The effects of reformulation: improved therapeutic index. | | Author(s) | Macdiarmid S, Sandage BW, Malhotra BK | | Institution | Alliance Urology Specialists, Bladder Control and Pelvic Pain Center, 509 North Elam Avenue, Second Floor, Greensboro, NC 27403, USA. smacdiarmid@allianceurology.com. | | Source | Curr Urol Rep 2008 Nov; 9(6):465-71. | | Abstract | Antimuscarinic agents are the treatment of choice for overactive bladder syndrome. Due to the development of novel delivery systems, extended-release formulations of oxybutynin, tolterodine, and trospium chloride are now available. In addition to the convenience of once-daily dosing, the new formulations of these commonly prescribed agents have improved their therapeutic index, striking a better balance between efficacy and tolerability. | | Language | eng | | Pub Type(s) | Journal Article
| | PubMed ID | 18947511 |
|
